Clinical Research Detail Title Of Study Clinical trial to assess the safety and the efficacy of a new intravenous immune globulin (IGIV3I Grifols10%) in patients with idiopathic (immune) thrombocytopenic purpura. Disease Condition idiopathic (immune) thrombocytopenic purpura Phase of Trial Phase-3 Discipline Immunology Start date of Trial 8/1/2008 Closing Date of Trial 8/1/2011 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]